Global Ofatumumab Market Growth 2023-2028

Report ID: 1978428 | Published Date: Jan 2025 | No. of Page: 76 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Ofatumumab Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Ofatumumab by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Ofatumumab by Country/Region, 2017, 2022 & 2028
    2.2 Ofatumumab Segment by Type
        2.2.1 20mg/1mL
        2.2.2 20mg/0.4mL
        2.2.3 100mg/5mL
        2.2.4 Others
    2.3 Ofatumumab Sales by Type
        2.3.1 Global Ofatumumab Sales Market Share by Type (2017-2022)
        2.3.2 Global Ofatumumab Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Ofatumumab Sale Price by Type (2017-2022)
    2.4 Ofatumumab Segment by Application
        2.4.1 Relapsing-remitting Multiple Sclerosis
        2.4.2 Clinically Isolated Syndrome
        2.4.3 Active Secondary Progressive Multiple Sclerosis
        2.4.4 Others
    2.5 Ofatumumab Sales by Application
        2.5.1 Global Ofatumumab Sale Market Share by Application (2017-2022)
        2.5.2 Global Ofatumumab Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Ofatumumab Sale Price by Application (2017-2022)
3 Global Ofatumumab by Company
    3.1 Global Ofatumumab Breakdown Data by Company
        3.1.1 Global Ofatumumab Annual Sales by Company (2020-2022)
        3.1.2 Global Ofatumumab Sales Market Share by Company (2020-2022)
    3.2 Global Ofatumumab Annual Revenue by Company (2020-2022)
        3.2.1 Global Ofatumumab Revenue by Company (2020-2022)
        3.2.2 Global Ofatumumab Revenue Market Share by Company (2020-2022)
    3.3 Global Ofatumumab Sale Price by Company
    3.4 Key Manufacturers Ofatumumab Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Ofatumumab Product Location Distribution
        3.4.2 Players Ofatumumab Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ofatumumab by Geographic Region
    4.1 World Historic Ofatumumab Market Size by Geographic Region (2017-2022)
        4.1.1 Global Ofatumumab Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Ofatumumab Annual Revenue by Geographic Region
    4.2 World Historic Ofatumumab Market Size by Country/Region (2017-2022)
        4.2.1 Global Ofatumumab Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Ofatumumab Annual Revenue by Country/Region
    4.3 Americas Ofatumumab Sales Growth
    4.4 APAC Ofatumumab Sales Growth
    4.5 Europe Ofatumumab Sales Growth
    4.6 Middle East & Africa Ofatumumab Sales Growth
5 Americas
    5.1 Americas Ofatumumab Sales by Country
        5.1.1 Americas Ofatumumab Sales by Country (2017-2022)
        5.1.2 Americas Ofatumumab Revenue by Country (2017-2022)
    5.2 Americas Ofatumumab Sales by Type
    5.3 Americas Ofatumumab Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Ofatumumab Sales by Region
        6.1.1 APAC Ofatumumab Sales by Region (2017-2022)
        6.1.2 APAC Ofatumumab Revenue by Region (2017-2022)
    6.2 APAC Ofatumumab Sales by Type
    6.3 APAC Ofatumumab Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Ofatumumab by Country
        7.1.1 Europe Ofatumumab Sales by Country (2017-2022)
        7.1.2 Europe Ofatumumab Revenue by Country (2017-2022)
    7.2 Europe Ofatumumab Sales by Type
    7.3 Europe Ofatumumab Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Ofatumumab by Country
        8.1.1 Middle East & Africa Ofatumumab Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Ofatumumab Revenue by Country (2017-2022)
    8.2 Middle East & Africa Ofatumumab Sales by Type
    8.3 Middle East & Africa Ofatumumab Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Ofatumumab
    10.3 Manufacturing Process Analysis of Ofatumumab
    10.4 Industry Chain Structure of Ofatumumab
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Ofatumumab Distributors
    11.3 Ofatumumab Customer
12 World Forecast Review for Ofatumumab by Geographic Region
    12.1 Global Ofatumumab Market Size Forecast by Region
        12.1.1 Global Ofatumumab Forecast by Region (2023-2028)
        12.1.2 Global Ofatumumab Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Ofatumumab Forecast by Type
    12.7 Global Ofatumumab Forecast by Application
13 Key Players Analysis
    13.1 Glaxosmithkline Inc
        13.1.1 Glaxosmithkline Inc Company Information
        13.1.2 Glaxosmithkline Inc Ofatumumab Product Offered
        13.1.3 Glaxosmithkline Inc Ofatumumab Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Glaxosmithkline Inc Main Business Overview
        13.1.5 Glaxosmithkline Inc Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Ofatumumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Ofatumumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of 20mg/1mL
    Table 4. Major Players of 20mg/0.4mL
    Table 5. Major Players of 100mg/5mL
    Table 6. Major Players of Others
    Table 7. Global Ofatumumab Sales by Type (2017-2022) & (K Units)
    Table 8. Global Ofatumumab Sales Market Share by Type (2017-2022)
    Table 9. Global Ofatumumab Revenue by Type (2017-2022) & ($ million)
    Table 10. Global Ofatumumab Revenue Market Share by Type (2017-2022)
    Table 11. Global Ofatumumab Sale Price by Type (2017-2022) & (US$/Unit)
    Table 12. Global Ofatumumab Sales by Application (2017-2022) & (K Units)
    Table 13. Global Ofatumumab Sales Market Share by Application (2017-2022)
    Table 14. Global Ofatumumab Revenue by Application (2017-2022)
    Table 15. Global Ofatumumab Revenue Market Share by Application (2017-2022)
    Table 16. Global Ofatumumab Sale Price by Application (2017-2022) & (US$/Unit)
    Table 17. Global Ofatumumab Sales by Company (2020-2022) & (K Units)
    Table 18. Global Ofatumumab Sales Market Share by Company (2020-2022)
    Table 19. Global Ofatumumab Revenue by Company (2020-2022) ($ Millions)
    Table 20. Global Ofatumumab Revenue Market Share by Company (2020-2022)
    Table 21. Global Ofatumumab Sale Price by Company (2020-2022) & (US$/Unit)
    Table 22. Key Manufacturers Ofatumumab Producing Area Distribution and Sales Area
    Table 23. Players Ofatumumab Products Offered
    Table 24. Ofatumumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 25. New Products and Potential Entrants
    Table 26. Mergers & Acquisitions, Expansion
    Table 27. Global Ofatumumab Sales by Geographic Region (2017-2022) & (K Units)
    Table 28. Global Ofatumumab Sales Market Share Geographic Region (2017-2022)
    Table 29. Global Ofatumumab Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 30. Global Ofatumumab Revenue Market Share by Geographic Region (2017-2022)
    Table 31. Global Ofatumumab Sales by Country/Region (2017-2022) & (K Units)
    Table 32. Global Ofatumumab Sales Market Share by Country/Region (2017-2022)
    Table 33. Global Ofatumumab Revenue by Country/Region (2017-2022) & ($ millions)
    Table 34. Global Ofatumumab Revenue Market Share by Country/Region (2017-2022)
    Table 35. Americas Ofatumumab Sales by Country (2017-2022) & (K Units)
    Table 36. Americas Ofatumumab Sales Market Share by Country (2017-2022)
    Table 37. Americas Ofatumumab Revenue by Country (2017-2022) & ($ Millions)
    Table 38. Americas Ofatumumab Revenue Market Share by Country (2017-2022)
    Table 39. Americas Ofatumumab Sales by Type (2017-2022) & (K Units)
    Table 40. Americas Ofatumumab Sales Market Share by Type (2017-2022)
    Table 41. Americas Ofatumumab Sales by Application (2017-2022) & (K Units)
    Table 42. Americas Ofatumumab Sales Market Share by Application (2017-2022)
    Table 43. APAC Ofatumumab Sales by Region (2017-2022) & (K Units)
    Table 44. APAC Ofatumumab Sales Market Share by Region (2017-2022)
    Table 45. APAC Ofatumumab Revenue by Region (2017-2022) & ($ Millions)
    Table 46. APAC Ofatumumab Revenue Market Share by Region (2017-2022)
    Table 47. APAC Ofatumumab Sales by Type (2017-2022) & (K Units)
    Table 48. APAC Ofatumumab Sales Market Share by Type (2017-2022)
    Table 49. APAC Ofatumumab Sales by Application (2017-2022) & (K Units)
    Table 50. APAC Ofatumumab Sales Market Share by Application (2017-2022)
    Table 51. Europe Ofatumumab Sales by Country (2017-2022) & (K Units)
    Table 52. Europe Ofatumumab Sales Market Share by Country (2017-2022)
    Table 53. Europe Ofatumumab Revenue by Country (2017-2022) & ($ Millions)
    Table 54. Europe Ofatumumab Revenue Market Share by Country (2017-2022)
    Table 55. Europe Ofatumumab Sales by Type (2017-2022) & (K Units)
    Table 56. Europe Ofatumumab Sales Market Share by Type (2017-2022)
    Table 57. Europe Ofatumumab Sales by Application (2017-2022) & (K Units)
    Table 58. Europe Ofatumumab Sales Market Share by Application (2017-2022)
    Table 59. Middle East & Africa Ofatumumab Sales by Country (2017-2022) & (K Units)
    Table 60. Middle East & Africa Ofatumumab Sales Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Ofatumumab Revenue by Country (2017-2022) & ($ Millions)
    Table 62. Middle East & Africa Ofatumumab Revenue Market Share by Country (2017-2022)
    Table 63. Middle East & Africa Ofatumumab Sales by Type (2017-2022) & (K Units)
    Table 64. Middle East & Africa Ofatumumab Sales Market Share by Type (2017-2022)
    Table 65. Middle East & Africa Ofatumumab Sales by Application (2017-2022) & (K Units)
    Table 66. Middle East & Africa Ofatumumab Sales Market Share by Application (2017-2022)
    Table 67. Key Market Drivers & Growth Opportunities of Ofatumumab
    Table 68. Key Market Challenges & Risks of Ofatumumab
    Table 69. Key Industry Trends of Ofatumumab
    Table 70. Ofatumumab Raw Material
    Table 71. Key Suppliers of Raw Materials
    Table 72. Ofatumumab Distributors List
    Table 73. Ofatumumab Customer List
    Table 74. Global Ofatumumab Sales Forecast by Region (2023-2028) & (K Units)
    Table 75. Global Ofatumumab Sales Market Forecast by Region
    Table 76. Global Ofatumumab Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 77. Global Ofatumumab Revenue Market Share Forecast by Region (2023-2028)
    Table 78. Americas Ofatumumab Sales Forecast by Country (2023-2028) & (K Units)
    Table 79. Americas Ofatumumab Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 80. APAC Ofatumumab Sales Forecast by Region (2023-2028) & (K Units)
    Table 81. APAC Ofatumumab Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 82. Europe Ofatumumab Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Europe Ofatumumab Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Middle East & Africa Ofatumumab Sales Forecast by Country (2023-2028) & (K Units)
    Table 85. Middle East & Africa Ofatumumab Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 86. Global Ofatumumab Sales Forecast by Type (2023-2028) & (K Units)
    Table 87. Global Ofatumumab Sales Market Share Forecast by Type (2023-2028)
    Table 88. Global Ofatumumab Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 89. Global Ofatumumab Revenue Market Share Forecast by Type (2023-2028)
    Table 90. Global Ofatumumab Sales Forecast by Application (2023-2028) & (K Units)
    Table 91. Global Ofatumumab Sales Market Share Forecast by Application (2023-2028)
    Table 92. Global Ofatumumab Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 93. Global Ofatumumab Revenue Market Share Forecast by Application (2023-2028)
    Table 94. Glaxosmithkline Inc Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
    Table 95. Glaxosmithkline Inc Ofatumumab Product Offered
    Table 96. Glaxosmithkline Inc Ofatumumab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 97. Glaxosmithkline Inc Main Business
    Table 98. Glaxosmithkline Inc Latest Developments
    Table 99. Novartis Basic Information, Ofatumumab Manufacturing Base, Sales Area and Its Competitors
    Table 100. Novartis Ofatumumab Product Offered
    Table 101. Novartis Ofatumumab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 102. Novartis Main Business
    Table 103. Novartis Latest Developments
List of Figures
    Figure 1. Picture of Ofatumumab
    Figure 2. Ofatumumab Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Ofatumumab Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Ofatumumab Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Ofatumumab Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of 20mg/1mL
    Figure 10. Product Picture of 20mg/0.4mL
    Figure 11. Product Picture of 100mg/5mL
    Figure 12. Product Picture of Others
    Figure 13. Global Ofatumumab Sales Market Share by Type in 2021
    Figure 14. Global Ofatumumab Revenue Market Share by Type (2017-2022)
    Figure 15. Ofatumumab Consumed in Relapsing-remitting Multiple Sclerosis
    Figure 16. Global Ofatumumab Market: Relapsing-remitting Multiple Sclerosis (2017-2022) & (K Units)
    Figure 17. Ofatumumab Consumed in Clinically Isolated Syndrome
    Figure 18. Global Ofatumumab Market: Clinically Isolated Syndrome (2017-2022) & (K Units)
    Figure 19. Ofatumumab Consumed in Active Secondary Progressive Multiple Sclerosis
    Figure 20. Global Ofatumumab Market: Active Secondary Progressive Multiple Sclerosis (2017-2022) & (K Units)
    Figure 21. Ofatumumab Consumed in Others
    Figure 22. Global Ofatumumab Market: Others (2017-2022) & (K Units)
    Figure 23. Global Ofatumumab Sales Market Share by Application (2017-2022)
    Figure 24. Global Ofatumumab Revenue Market Share by Application in 2021
    Figure 25. Ofatumumab Revenue Market by Company in 2021 ($ Million)
    Figure 26. Global Ofatumumab Revenue Market Share by Company in 2021
    Figure 27. Global Ofatumumab Sales Market Share by Geographic Region (2017-2022)
    Figure 28. Global Ofatumumab Revenue Market Share by Geographic Region in 2021
    Figure 29. Global Ofatumumab Sales Market Share by Region (2017-2022)
    Figure 30. Global Ofatumumab Revenue Market Share by Country/Region in 2021
    Figure 31. Americas Ofatumumab Sales 2017-2022 (K Units)
    Figure 32. Americas Ofatumumab Revenue 2017-2022 ($ Millions)
    Figure 33. APAC Ofatumumab Sales 2017-2022 (K Units)
    Figure 34. APAC Ofatumumab Revenue 2017-2022 ($ Millions)
    Figure 35. Europe Ofatumumab Sales 2017-2022 (K Units)
    Figure 36. Europe Ofatumumab Revenue 2017-2022 ($ Millions)
    Figure 37. Middle East & Africa Ofatumumab Sales 2017-2022 (K Units)
    Figure 38. Middle East & Africa Ofatumumab Revenue 2017-2022 ($ Millions)
    Figure 39. Americas Ofatumumab Sales Market Share by Country in 2021
    Figure 40. Americas Ofatumumab Revenue Market Share by Country in 2021
    Figure 41. United States Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Canada Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Mexico Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Brazil Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 45. APAC Ofatumumab Sales Market Share by Region in 2021
    Figure 46. APAC Ofatumumab Revenue Market Share by Regions in 2021
    Figure 47. China Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Japan Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 49. South Korea Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Southeast Asia Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 51. India Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Australia Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Europe Ofatumumab Sales Market Share by Country in 2021
    Figure 54. Europe Ofatumumab Revenue Market Share by Country in 2021
    Figure 55. Germany Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 56. France Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 57. UK Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Italy Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Russia Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Middle East & Africa Ofatumumab Sales Market Share by Country in 2021
    Figure 61. Middle East & Africa Ofatumumab Revenue Market Share by Country in 2021
    Figure 62. Egypt Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 63. South Africa Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Israel Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 65. Turkey Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 66. GCC Country Ofatumumab Revenue Growth 2017-2022 ($ Millions)
    Figure 67. Manufacturing Cost Structure Analysis of Ofatumumab in 2021
    Figure 68. Manufacturing Process Analysis of Ofatumumab
    Figure 69. Industry Chain Structure of Ofatumumab
    Figure 70. Channels of Distribution
    Figure 71. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Ofatumumab Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Ofatumumab Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Ofatumumab Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports